The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma

The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma

Background: Patients with stage I cutaneous melanoma (CM) are considered at low risk for metastasis or melanoma specific death; however, because the majority of patients are diagnosed with stage I disease, they represent the largest number of melanoma deaths annually. The 31-gene expression profile...

Full description

Bibliographic Details
Main Authors: Sebastian Podlipnik, Brian J. Martin, Sonia K. Morgan-Linnell, Christine N. Bailey, Jennifer J. Siegel, Valentina I. Petkov, Susana Puig
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
31-gene expression profile
cutaneous melanoma
AJCC
prognosis
staging
gene expression profiling
Online Access:https://www.mdpi.com/2072-6694/16/2/287

Similar Items

Similar Items